Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing
Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants
Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline